Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Research on the Intervention of Myoless2.0 Effectiveness (PRIME) in Pediatric Population

NCT07394556 is registered in ClinicalTrials.gov with Indizen Optical Technologies, S.L.U. as lead sponsor.

NCT NCT07394556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Research on the Intervention of Myoless2.0 Effectiveness (PRIME) in Pediatric Population
Lead sponsor
Indizen Optical Technologies, S.L.U.
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
October 31, 2028
Enrollment
180 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myopia progression